SOURCE: Oasis Medical Inc.
GLENDORA, CA--(Marketwired - January 13, 2014) - OASIS Medical Inc., U.S. manufacturer and distributor of high quality disposable surgical instruments and ocular lubricating and cleansing solutions, jointly with Spain-based AJL Ophthalmic, S.A., manufacturer of ophthalmic implants,
announce an exclusive relationship for the sales and distribution of Intacs® corneal implants for the treatment of keratoconus and FDA approved for the treatment of myopia.
AJL Ophthalmic announced the acquisition of Addition Technologies in January 2013. Addition Technologies will continue the manufacturing and remain the FDA approved Humanitarian Device Exemption (HDE) holder of the device.
"OASIS is honored to work with AJL Ophthalmic S.A. and the Intacs device. Intacs serves keratoconus patients, giving them a truly extraordinary option to retain their visual acuity once contacts or glasses are no longer a viable option," said Craig Delgado, President of OASIS Medical Inc.
Keratoconus is a progressive disease where there is thinning and coning of the cornea that distorts vision and causes sensitivity to light. The corneal disease may progress to legal blindness and require a corneal transplant procedure. The cause of keratoconus is still unknown.
Intacs® is a unique corneal implant option that restores the natural shape of the cornea improving the patient's vision and potentially avoiding corneal transplants. The minimally invasive procedure has a recovery period of days rather than months when compared to a corneal transplant procedure.
About OASIS Medical Inc.
OASIS is a continuous improvement company deeply committed to truth in its business approach, relationships, and products based on our foundation of accountability. Our goal is to create a partnership for OASIS and the doctor so that both parties achieve a win. From the beginning, OASIS has been a practice-based company focused on building dry eye and surgical practices through the various tools we offer. OASIS invests in the long term through our strategic partnerships with eye care providers. This investment helps the doctor improve the quality of the patient's eye care experience. As consultants we are willing to invest time and equip the doctor with how our approach can assist their practice. This strategy allows OASIS to thrive by being relevant through focusing on the patient care experience and efficiency of the individual practice. Our values of integrity and quality guide our commitment to solution-based products that enhance patient care.
About AJL Ophthalmic S.A.
AJL Ophthalmic S.A., based in Spain, has over 15 years of experience in the manufacturing of ophthalmic implants; among them, intraocular lenses, corneal rings, glaucoma instruments, and others with very stringent quality standards regulated by European Notified Bodies. The internationalization of the company with the acquisition of Addition Technology Inc. (Intacs), IL, and its established distribution channels is an excellent opportunity for the introduction of AJL's broad line of ophthalmic products.
Image Available: http://www.marketwire.com/library/MwGo/2014/1/13/11G011354/Images/Intacs_On_Finger-18298169569.jpeg
Image Available: http://www.marketwire.com/library/MwGo/2014/1/13/11G011354/Images/intacs.before_and_after-817111393281.JPG
Embedded Video Available: https://www.youtube.com/watch?v=nI2dX8MyonQ